OE2.4.1: Commercial Society of Advanced Therapy Drugs (S-TA)
The objective of this public-private society is the research, development and potential commercialization of drugs in new advanced therapies in Spain. It has the participation of 51% by private companies: Rovi and Insud Pharma and 49% by the Ministry of Science, Innovation and Universities through Innvierte. More information in The Government approves the creation of the first commercial society of advanced therapies with public-private capital in Spain with the participation of the CDTI through Innvierte SICC (cdti.es).
